Skip to Content
Merck
CN
  • Methods for the detection of cytomegalovirus in glioblastoma cells and tissues.

Methods for the detection of cytomegalovirus in glioblastoma cells and tissues.

Methods in molecular biology (Clifton, N.J.) (2014-03-19)
Charles S Cobbs, Lisa Matlaf, Lualhati E Harkins
ABSTRACT

An increased awareness of the potential oncomodulatory properties of human cytomegalovirus (HCMV) has evolved over the last decade. We first reported the presence of HCMV in human glioblastomas, and subsequently these findings have been corroborated by other groups. However, some controversy has been associated with the immunohistochemical and in situ hybridization techniques used, since standard immunohistochemical and in situ hybridization techniques have been insufficient to detect low level HCMV antigens and nucleic acids in some tumor tissues. Here, we present detailed methods that can be used for the sensitive detection of low level HCMV antigens and nucleic acids in human glioblastoma specimens. Using these techniques, HCMV is frequently detected in frozen and formalin fixed paraffin-embedded tissue specimens. Furthermore, we demonstrate how human primary glioblastoma cells can be cultured in vitro, and how these cells can be used for detection of HCMV by immunofluorescence, in situ hybridization, western blot, and RT-PCR.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Actin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Cytomegalovirus Antibody, late Antigen, clone 1G5.2, clone 1G5.2, Chemicon®, from mouse